Literature DB >> 33639197

Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.

Annelies Noorlander1, Sebastiaan Wesseling2, Ivonne M C M Rietjens2, Bennard van Ravenzwaay3.   

Abstract

The present study aimed at incorporating active renal excretion via the organic cation transporter 2 (OCT2) into a generic rat physiologically based kinetic (PBK) model using an in vitro human renal proximal tubular epithelial cell line (SA7K) and mepiquat chloride (MQ) as the model compound. The Vmax (10.5 pmol/min/mg protein) and Km (20.6 μM) of OCT2 transport of MQ were determined by concentration-dependent uptake in SA7K cells using doxepin as inhibitor. PBK model predictions incorporating these values in the PBK model were 6.7-8.4-fold different from the reported in vivo data on the blood concentration of MQ in rat. Applying an overall scaling factor that also corrects for potential differences in OCT2 activity in the SA7K cells and in vivo kidney cortex and species differences resulted in adequate predictions for in vivo kinetics of MQ in rat (2.3-3.2-fold). The results indicate that using SA7K cells to define PBK parameters for active renal OCT2 mediated excretion with adequate scaling enables incorporation of renal excretion via the OCT2 transporter in PBK modelling to predict in vivo kinetics of mepiquat in rat. This study demonstrates a proof-of-principle on how to include active renal excretion into generic PBK models.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active renal excretion; Mepiquat; Organic cation transporter 2; Physiologically based kinetic modeling; Renal proximal tubule epithelial cell line; Scaling factor

Mesh:

Substances:

Year:  2021        PMID: 33639197     DOI: 10.1016/j.toxlet.2021.02.013

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.

Authors:  Frances Widjaja; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2021-10-20       Impact factor: 5.153

Review 2.  The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.

Authors:  Frances Widjaja; Yasser Alhejji; Ivonne M C M Rietjens
Journal:  Planta Med       Date:  2021-11-05       Impact factor: 3.352

3.  Application of the Adverse Outcome Pathway Concept to In Vitro Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case Study.

Authors:  Sebastian Jarzina; Stefano Di Fiore; Bernhard Ellinger; Pia Reiser; Sabrina Frank; Markus Glaser; Jiaqing Wu; Femke J Taverne; Nynke I Kramer; Angela Mally
Journal:  Front Toxicol       Date:  2022-04-19

4.  Use of Physiologically Based Kinetic Modeling-Facilitated Reverse Dosimetry to Predict In Vivo Acute Toxicity of Tetrodotoxin in Rodents.

Authors:  Annelies Noorlander; Mengying Zhang; Bennard van Ravenzwaay; Ivonne M C M Rietjens
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.